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Research
Exposure to ambient particulate matter (PM)
has been associated with increased hospital
admissions for cardiovascular disease, and
increased cardiovascular disease mortality
(Dockery 2001; Miller et al. 2007). Studies
have suggested that vascular, autonomic,
endothelial functioning and/or inﬂammation
are part of the mechanistic pathway (Brook
et al. 2002; Choi et al. 2007; Diez Roux et al.
2006; Gold et al. 2000; O’Neill et al. 2005);
yet much of the evidence has been weak or
inconclusive/null, or has come from small
studies and/or among persons with preexist-
ing disease. Thus, much remains to be
learned about the underlying mechanisms or
pathways of particle-induced mortality and
morbidity. High blood pressure (BP) is an
established risk factor for cardiovascular dis-
ease and may be implicated in the association
between ambient PM and cardiovascular
morbidity and mortality. 
PM ≤ 2.5 μm in aerodynamic diameter
(fine particles; PM2.5) can be effectively
inhaled and deposited in the airways and
alveolar surfaces, and thus have the potential
to elicit health impacts [U.S. Environmental
Protection Agency (EPA) 2004]. Inhaled par-
ticles may down-regulate nitric oxide synthase
and alter autonomic nervous system function-
ing (Gold et al. 2000; Haak et al. 1994)—
thus potentially affecting cardiac output,
arterial stiffening, vascular function and tone,
and wave reflections. Only one study
(Zanobetti et al. 2004, a repeated-measures
study among cardiac patients) has found a
positive association between ﬁne particles and
BP. Most studies examining ﬁne particles and
BP have found inverse (Brauer et al. 2001;
Ebelt et al. 2005; Ibald-Mulli et al. 2004) or
no (Jansen et al. 2005; Linn et al. 1999; Urch
et al. 2005) association. Studies to date have
examined PM2.5 effects among persons with
preexisting disease (chronic obstructive pul-
monary disease or cardiac disease) or a small
number of healthy individuals participating
in an exposure-chamber study. Studies in
general population samples are lacking.
Furthermore, prior studies have investigated
relatively short lags, ranging from same day to
the 5 prior days, with one repeated-measures
study examining 12-day exposure (Jansen
et al. 2005). 
We examined the cross-sectional relation-
ship between relatively short-term exposure to
PM2.5 (prior 1 day to prior 2 months) and
BP in a large population-based sample. We
hypothesized that recent exposure to PM2.5
would be positively associated with BP. We
also hypothesized that proxies for traffic-
related exposure would be associated with BP
and would modify the association between
background PM2.5 and BP, because near
roadways PM2.5 may be higher and/or more
toxic (Sanderson et al. 2005).
Materials and Methods
Study sample. Study participants, 45–84 years
of age, from the Multi-Ethnic Study of
Atherosclerosis (MESA) cohort were free of
clinically apparent cardiovascular disease
(symptoms, or history of medical or surgical
treatment). They were recruited from six U.S.
communities (Baltimore City and Baltimore
County, Maryland; Chicago, Illinois; Forsyth
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BACKGROUND: Blood pressure (BP) may be implicated in associations observed between ambient
particulate matter and cardiovascular morbidity and mortality. This study examined cross-
sectional associations between short-term ambient ﬁne particles (particulate matter ≤ 2.5 µm in
aerodynamic diameter; PM2.5) and BP: systolic (SBP), diastolic (DBP), mean arterial (MAP), and
pulse pressure (PP).
METHODS: The study sample included 5,112 persons 45–84 years of age, free of cardiovascular
disease at the Multi-Ethnic Study of Atherosclerosis baseline examination (2000–2002). Data from
U.S. Environmental Protection Agency monitors were used to estimate ambient PM2.5 exposures
for the preceding 1, 2, 7, 30, and 60 days. Roadway data were used to estimate local exposures to
trafﬁc-related particles. 
RESULTS: Results from linear regression found PP and SBP positively associated with PM2.5. For
example, a 10-µg/m3 increase in PM2.5 30-day mean was associated with 1.12 mmHg higher pulse
pressure [95% conﬁdence interval (CI), 0.28–1.97] and 0.99 mmHg higher systolic BP (95% CI,
–0.15 to 2.13), adjusted for age, sex, race/ethnicity, income, education, body mass index, diabetes,
cigarette smoking and environmental tobacco smoke, alcohol use, physical activity, medications,
atmospheric pressure, and temperature. Results were much weaker and not statistically signiﬁcant
for MAP and DBP. Although trafﬁc-related variables were not themselves associated with BP, the
association between PM2.5 and BP was stronger in the presence of higher trafﬁc exposure. 
CONCLUSIONS: Higher SBP and PP were associated with ambient levels of PM2.5 and the associa-
tion was stronger in the presence of roadway trafﬁc, suggesting that impairment of blood pressure
regulation may play a role in response to air pollution.
KEY WORDS: air pollution, blood pressure, cardiovascular disease, epidemiology, particulate matter.
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[Online 24 January 2008]County, North Carolina; Los Angeles County,
California; Northern Manhattan and the
Bronx, New York; and St. Paul, Minnesota)
with a variety of population-based approaches,
including commercial lists of area residents
and random-digit dialing, as previously
reported (Bild et al. 2002). In the present
study we used data from the baseline visit
occurring between July 2000 and August
2002; most (52%) participants were enrolled
in 2001. The study was approved by each
study site’s institutional review board. All par-
ticipants provided written informed consent. 
Air pollution and meteorology data. We
extracted pollutant data from the U.S. EPA’s
Aerometric Information Retrieval System
(U.S. EPA 2003). PM2.5 concentrations were
obtained from 24-hr integrated samplers,
which collected data daily or every third day.
For each person, we created a set of PM2.5
concentrations representing exposure before
the clinical examination based on concentra-
tions from the monitor nearest to the person’s
residence with available data on a given day.
Five exposure measures were constructed:
prior day, average of the prior 2 days, prior
7 days, prior 30 days, and prior 60 days.
Gaseous pollutants (sulfur dioxide, nitro-
gen dioxide, carbon monoxide), which are
related to PM2.5 and potentially related to BP
(Bhatnagar 2006), were also included. Ozone
was not included because there was incom-
plete information in the winter. National
Weather Service (National Climatic Data
Center 2004) meteorologic variables (daily
average temperature and sea-level barometric
pressure) were included because of their strong
associations with PM2.5 and BP (Woodhouse
et al. 1993). Methods for co-pollutant and
meterologic measures have been reported else-
where (Diez Roux et al. 2006). Cumulative
exposures for weather and co-pollutants were
computed in the same way as PM2.5.
Proxies for traffic-related exposure were
straight-line distance to a highway; total road
length around the residence; and NO2,
because it is a large component of trafﬁc emis-
sions (Brauer et al. 2002). The roadway file,
obtained from the Environmental Systems
Research Institute Inc. (ESRI, Redlands, CA),
was a modified version of the 1990 Census
TIGER/Line ﬁle. The modiﬁcations improved
positional accuracy of the line ﬁle, eliminated
errant segments, and appropriately reclassiﬁed/
corrected features [Geographic Data Tech-
nology (GDT) and ESRI 2002]. Residences
within 300 m of a major road were deﬁned as
being “close to a highway.” Major roads were
selected because they were likely to have diesel
(truck) traffic (Brunekreef et al. 1997) and
were identiﬁed from census feature class codes
for primary roads (A1 or A2). A distance of
300 m was chosen for a few reasons: to obtain
a reasonable distribution of residences in the
two exposure categories, because trafﬁc-related
pollutants typically drop off to background
levels around 300 m (Sanderson et al. 2005),
and because potential spatial inaccuracies (Wu
et al. 2005) in the relative positioning of our
roadway data and participant addresses pre-
cluded accurate measures of very short dis-
tances. Total road length (major plus
connecting roads) was calculated for a 400-m
(0.25-mile) area around the residence and
used as both a continuous and a binary vari-
able (total road length ≥ 3.5 km, top quartile).
Clinical measurements. We obtained infor-
mation on person-level covariates during the
clinical examination: age, sex, race/ethnicity,
income, education, body mass index (BMI),
type 2 diabetes [defined by the American
Diabetes Association 2003 criteria (Genuth
et al. 2003)], cigarette smoking, environmental
tobacco smoke (ETS; during past year
≥ 1 hr/week in “close quarters” with a person
who smoked at home, at work, in a car, etc.),
high alcohol use (average weekly drinks was
≥ 7, top 10th percentile), sodium intake, physi-
cal activity, and BP medications. These vari-
ables are potential confounders because they are
associated with BP outcomes and may be asso-
ciated with residential location and therefore
with PM and trafﬁc exposures. We calculated
per capita income by dividing the interval mid-
point of family income (total combined family
income for the preceding 12 months from 13
income categories, in U.S. dollars) by the num-
ber of persons supported. Dietary sodium
intake was included in exploratory models
(results were very similar), but not included in
ﬁnal models because a large proportion of data
was missing. Antihypertension medication use
was deﬁned as using any of the common classes
of antihypertensive medications: thiazide
diuretics, β-blockers, calcium channel blockers,
angiotensin-converting enzyme inhibitors,
angiotensin-2 receptor blockers, and other
α-blockers or peripheral vasodilators. (Results
were very similar when medications were sepa-
rated into classes of medications.) 
Resting seated BP was measured three
times at 1-min intervals using an automated
oscillometric sphygmomanometer (Dinamap
PRO 100; Critikon, Tampa, FL). The average
of the second and third BP measurements was
used for these analyses. The mechanisms
through which PM exposures may affect BP
(and hence the aspect of BP likely to be most
sensitive to exposures) are unknown. We
therefore examined a variety of BP parameters
including systolic BP (SBP), diastolic BP
(DBP), pulse pressure (PP; systolic–diastolic),
and mean arterial pressure {MAP; [(2 × dias-
tolic) + systolic]/3}. 
Of the 6,814 participants who completed
the clinical examination, 6,181 participated in
the air pollution study. Of these persons, there
were exclusions due to address errors (n = 149)
or missing information on BP (n = 3), air pollu-
tion exposure (n = 661), and other covariates
(n = 256). Therefore, data on 5,112 partici-
pants were available for analysis. The demo-
graphic characteristics of this subset were
similar to those excluded (n = 1,702), except
that excluded participants were less likely to be
Caucasian (37% vs. 44%), had lower per capita
family income ($21,700 vs. $26,400), were
more likely to be from the St. Paul study site
(St. Paul had a small number of PM monitors
and infrequent data collection), and less likely
to be from the Chicago site (8% vs. 21%). 
Statistical analysis. We used ordinary
least-squares regression to separately estimate
associations between BP and a 10-μg/m3
increase in PM2.5, using various PM2.5 averag-
ing periods before and after adjustment for
confounders: age, sex, race/ethnicity, per
capita family income, education, BMI, dia-
betes status, cigarette smoking status, exposure
to ETS, high alcohol use, physical activity, BP
medication use, meteorology variables, and co-
pollutants. Adjustment for confounders was
performed in stages to identify which con-
founders had a strong inﬂuence on results. 
Our statistical analyses relied on variability
in particle concentrations between days and
between study sites. Thus, adjustment for
study site may reduce our ability to detect an
association between particles and blood pres-
sure. Nevertheless, because particle composi-
tion may vary by study site and may be
associated with BP through mechanisms not
already controlled for (Diez Roux et al. 2002;
Lakoski et al. 2005), we also examined associa-
tions after adjustment for site as well as hetero-
geneity in associations by site. We examined
associations between BP and traffic-related
variables using the same sequential modeling
approach used for PM2.5. 
We investigated heterogeneity in the associ-
ation between PM2.5 and BP by levels of trafﬁc-
related exposures [living close (≤ 300 m) to a
highway, surrounded by a high density of
roads, high NO2 exposure], for levels of SO2
and CO, and for weather variables. “High”
levels were deﬁned as the top quartiles of these
variables. Heterogeneity of effects was also
examined by age, sex, type 2 diabetes, hyper-
tensive status, and cigarette use. Older per-
sons, women (Künzli et al. 2005; Miller et al.
2007), and people with diabetes (O’Neill et al.
2005) and hypertension may be more vulnera-
ble to the effects of air pollution; and direct
inhalation of PM from cigarettes may over-
whelm any effects because of ambient particle
exposure. We tested heterogeneity of effects by
stratification and by including interaction
terms in regression models. 
Because BP medications potentially have a
strong inﬂuence on continuous BP, medication
use was controlled for; heterogeneity of
effects by medication use was examined; and
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to ﬁt a binary hypertension outcome (any of
the following: SBP ≥ 140 mmHg, DBP
≥ 90 mmHg, self reported history of hyper-
tension, use of hypertensive medication)
(Chobanian et al. 2003).
We assessed nonlinear covariate-adjusted
relationships between all independent vari-
ables and BP outcomes (Hastie 1992). There
was no evidence of strong threshold/nonlinear
effects for PM2.5 although nonlinearity was
evident among co-pollutants; thus, we fit
ordinary least squares regression with piece-
wise linear functions as appropriate.
We confirmed that multivariable regres-
sion variance inflation factors (VIF) did not
diagnose high collinearity; VIF = 10 was used
to deﬁne high multicollinearity (Belsley et al.
1980; Kleinbaum et al. 1998).
Because seasons vary by our study sites,
primary analyses used temperature and baro-
metric pressure to adjust for seasonality.
Sensitivity analyses evaluated whether there
was seasonal residual confounding or autocor-
relation not accounted for by weather vari-
ables. Main results were stratified by season.
Results were also examined before and after
adding a smoothing spline [in generalized
additive models (Hastie 1992)] for season.
We assessed autocorrelation among regression
residuals via autoregressive generalized estima-
tion models (Littell et al. 1996), by examining
the Durbin–Watson statistic in ordinary least-
squares regression (Durbin and Watson
1951), and plotting residuals against time
(time represented BP collection year–month
and also season).
Sensitivity analyses also evaluated the
robustness of results to exposure misspeciﬁca-
tion. Analyses using PM2.5 were repeated
a) restricting analyses to participants living
relatively close (20 km) to PM2.5 monitors;
and b) stratifying results by the years the par-
ticipant lived at the address and the amount
of time each week spent within that neighbor-
hood. We also repeated analyses for proximity
of highways using continuous distance to
highways and an alternate binary measure
(≤ 400 m from a highway). 
Results
Mean age in the study sample was 62 years,
approximately half were female, mean BMI
was 28 kg/m2, 45% had hypertension, and
38% were taking BP medications (Table 1).
Prior 30-day mean PM2.5 was highly correlated
with prior 60-day mean PM2.5 (Spearman r =
0.87) but more weakly correlated with other
time periods [r = 0.67, 0.48, and 0.41, for
prior 7-, 2-, and 1-day(s), respectively] [see
Supplemental Material (online at http://www.
ehponline.org/members/2008/10899/suppl.
pdf) for more correlations]. Mean 30-day
PM2.5 was highest in Los Angeles (21.8 μg/m3)
and lowest in St. Paul (10.3 μg/m3), and 29%
of the sample lived close to a highway. Mean
PM2.5 was much higher where NO2 was high
(19.9 vs. 15.7 μg/m3) but PM2.5 levels varied
little with other traffic-related variables.
Patterns were similar for prior 1-, 2-, 7-, and
60-day exposures (data not shown.) 
Table 2 shows adjusted associations of
PM2.5 with BP outcomes. We present results
only for PP and SBP. None of the DBP
results were statistically signiﬁcant. Results for
MAP were similar to SBP, though weaker and
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Table 1. Demographic characteristics, BP, and environmental characteristics, MESA 2000–2002 (n = 5,112).
Variable Value PM2.5 prior 30 days (mean ± SD)
Demographic characteristics
Age [years (mean ± SD)]  62.3 ± 10.0
Female (%) 52
Race/ethnicity (%)
Caucasian 37
Chinese 14
African American 28
Hispanic 21
Per capita income [per $1,000 (mean ± SD)]  27 ± 21
No college education (%) 34
BMI [kg/m2 (mean ± SD)]  28.2 ± 5.4
Diabetes (%)
No diabetes or impairment 58
Impaired glucose tolerance 29
Diabetes 14
Smoking status (%)
Never 51
Former 37
Current 12
Environmental tobacco smoke (%)
≥ 1 hour per week 33
High alcohol use (%)
High (top 10th percentile, ≥ 7 drinks per week) 12
Physical activitya
Low 28
Medium 49
High 23
Taking medications for blood pressure (%) 38
Blood pressure
Systolic blood pressure [mmHg (mean ± SD)] 126.5 ± 21.0
Dystolic blood pressure [mmHg (mean ± SD)] 72.0 ± 10.2
Pulse pressure [mmHg (mean ± SD)] 54.4 ± 16.9
Arterial pressure (mean ± SD) 90.2 ± 12.4
Hypertensionb (%) 45
Environmental characteristics
PM2.5 [µg/m3 (mean ± SD)]c
Prior day 17.0 ± 10.5
Prior 2 days 16.8 ± 9.3
Prior 7 days 17.0 ± 6.9
Prior 30 days 16.8 ± 5.0
Prior 60 days 16.7 ± 4.4
Study site (%)
Los Angeles County, CA 22 21.8 ± 5.4
Chicago, IL 20 16.7 ± 3.9
Baltimore, MD 17 15.9 ± 3.6
St. Paul, MN 8 10.3 ± 2.4
Forsyth County, NC 16 15.4 ± 3.3
Northern Manhattan and Bronx, NY 18 15.4 ± 2.9
Trafﬁc-relatedd
Close to a highway (%)
No 71 16.9 ± 5.2
Yes 29 16.5 ± 4.3
Surrounded by a high density of roads (%)
No 75 16.9 ± 5.2
Yes 25 16.5 ± 4.1
NO2, prior 30 days (%)
Low 75 15.7 ± 4.1
High 25 19.9 ± 5.9
aReported total physical activity classiﬁed based on the lowest and highest quartiles: low < 9 hr/day, medium 9–16 hr/day,
high > 16 hr/day. bHaving any of the following: DBP ≥ 90, SBP ≥ 140, self-reported history of hypertension, use of hyper-
tensive medication (Chobanian et al. 2003). cThe 2006 National Ambient Air Quality Standards for PM2.5: 15 µg/m3 for
annual mean and 35 µg/m3 for 24-hr mean (U.S. EPA 2006). dClose to a highway was ≤ 300m of a major road. Surrounded
by a high density of roads was deﬁned as ≥ 3.5 km (top quartile) of road length within 400 m of the residence. High NO2
was deﬁned as 0.0325 ppm (top quartile). This cut point for NO2 is much lower than the annual NAAQS of 0.053 ppm.generally not statistically signiﬁcant. Results for
DBP and MAP are shown in Supplemental
Material (online at http://www.ehponline.org/
members/2008/10899/suppl.pdf) (results for
DBP can be derived by subtracting the PP
from SBP values shown in Table 2). PP and
SBP were generally associated with individual-
level covariates in the expected direction, and
meteorology variables (temperature and
atmospheric pressure) were positively associ-
ated with BP (data not shown). Adjusted for
age, sex, race/ethnicity, income, education,
BMI, diabetes, cigarette smoking, alcohol use,
physical activity, BP medication, and meteo-
rology variables, a 10-μg/m3 increase in PM2.5
was associated with 1.12 mmHg higher PP
[95% confidence interval (CI), 0.28–1.97]
and 0.99 mmHg higher SBP [although CIs
included the null value (95% CI, –0.15 to
2.13), model 2]. Results were noticeably
stronger after adjustment for gaseous co-pol-
lutants [per 10-μg/m3 increase in PM2.5, PP
was 2.66 higher (95% CI, 1.61–3.71] and
SBP was 2.80 higher (95% CI, 1.38–4.22),
model 2a]; the impact was greatest after
adding NO2 to the models [Supplemental
Material (online at http://www.ehponline.
org/members/2008/10899/suppl.pdf) shows
regression estimates for the co-pollutants].
Adding site to model 2 had no effect on PP,
but strengthened the SBP results while widen-
ing CIs [per 10-μg/m3 increase in PM2.5 there
was a 1.32 (95% CI: –0.18 to 2.82) increase
in SBP, model 3a]. 
Associations between PM2.5 and BP
became stronger with longer PM2.5 averaging
periods up to 30 days. For example, per
10-μg/m3 difference in PM2.5 adjusted for
covariates in model 2, the difference in PP
was –0.38 mmHg for 1 day (95% CI, –0.76
to 0.00); –0.22 mmHg for 2 days (95% CI,
–0.65 to 0.21); 0.52 mmHg for 7 days (95%
CI, –0.08 to 1.11); 1.12 mmHg for 30 days
(0.28 to 1.97); and 1.08 mmHg for 60 days
(95% CI, 0.11 to 2.05). This pattern held
true for other person-level adjustments and
for SBP, so only results for the 30-day mean
differences are shown [see Supplemental
Material (online at http://www.ehponline.
org/members/2008/10899/suppl.pdf) for the
60-day averages]. 
We examined comparable models for traf-
fic-related exposures. Associations with BP
were opposite expectation (negative) and gen-
erally statistically signiﬁcant [see Supplemental
Material (online at http://www.ehponline.org/
members/2008/10899/suppl.pdf) for results].
After adjustment for study site, the magnitude
of the associations decreased, and most CIs
included the null value. Results were similar
when adjusted for ambient PM2.5 exposure.
The associations of PM2.5 with BP were
not modified by age, sex, diabetes, cigarette
use, study site, high levels of CO or SO2, sea-
son, nor residence ≤ 400 m from a highway
(tests for interaction, all p ≥ 0.2). Figure 1
shows variables for which interactions were
p ≤ 0.1 for either PP or SBP [see Supplemental
Material (online at http://www.ehponline.
org/members/2008/10899/suppl.pdf) for all
heterogeneity analyses]. Associations between
PM2.5 and BP were stronger for persons taking
medications, with hypertension, during
warmer weather, in the presence of high NO2,
residing ≤ 300 m from a highway, and
surrounded by a high density of roads.
Sensitivity analyses that examined results
restricted to persons who lived relatively close
(≤ 20 km) to their PM2.5 monitors found
similar (though stronger) results, and infer-
ence generally remained the same. Results
were insensitive to the number of years spent
living in the residence and the percentage of
time during a week spent in the neighbor-
hood. (On average, participants lived 15 years
in their neighborhood and spent 75% of their
time within their neighborhood.) 
There was no strong evidence of seasonal
residual autocorrelation: the Durbin–Watson
statistic was normal, and plots of residuals
against time (time represented season and BP
collection year–month) did not show strong
patterning. Results were very similar when a
smoothing spline for season was added to the
model and when structured covariance mod-
els allowed for autocorrelation between
months [see Supplemental Material (online at
http://www.ehponline.org/members/2008/
10899/suppl.pdf)]. 
Secondary analyses that replaced the con-
tinuous BP outcome with binary hypertension
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Table 2. Adjusted mean differences (95% CIs) in PP and SBP (mmHg) per 10-ug/m3 increase in PM2.5 (averaged for the prior 1–30 days) (n = 5,112), MESA, 2000–2002.
PP SBP
Model no. Adjustment variables Mean difference 95% CI p-Value Mean difference 95% CI p-Value
1 Person-level covariatesa 1.04 0.25 to 1.84 0.010 0.66 –0.41 to 1.74 0.226
2 Person-level covariates,a weatherb 1.12 0.28 to 1.97 0.009 0.99 –0.15 to 2.13 0.089
2a Person-level covariates,a weather,b gaseous co-pollutantsc 2.66 1.61 to 3.71 0.000 2.8 1.38 to 4.22 0.000
3 Person-level covariates,a study site 0.93 –0.04 to 1.90 0.060 0.86 –0.45 to 2.17 0.200
3a Person-level covariates,a study site, weatherb 1.11 0.01 to 2.22 0.049 1.32 –0.18 to 2.82 0.085
3b Person-level covariates,a study site, weather,b gaseous co-pollutantsc 1.34 0.10 to 2.59 0.035 1.52 –0.16 to 3.21 0.077
Adjusted relationships between blood pressure and temperature and SO2 were ﬁt using piecewise linear splines because they are positive for lower values and negative for higher val-
ues (breaks at 45ºF for temperature and 0.004 ppm for SO2). 
aAge, sex, race/ethnicity, per capita income, education, BMI, diabetes status, cigarette smoking, exposure to ETS, alcohol use, physical activity, medications. bPrior 30-day mean for
temperature and sea-level pressure. cPrior 30-day mean for NO2, SO2, and CO. 
Figure 1. Stratified estimates (95% CIs) of the difference in PP and SBP per 10-µg/m3 increase in PM2.5
prior 30-day average, adjusted for model 2 covariates (except the stratiﬁcation by temperature, which was
adjusted for model 1 covariates). All tests for interactions were p < 0.09 except for Close to a highway:
p < 0.3 for SBP. 
PP (mmHg) SBP (mmHg)
No
Cool (< 50°F)
< Median (0.0325 ppm)
No
No
Blood pressure medications
Yes
Not hypertensive
Hypertensive
Temperature
Moderate (50 to < 62°F)
Warm (≥ 62°F)
NO2
≥ Median
Close (300 m) to a highway
Yes
Yes
High density of roads (≥ 3.5 km
road length within 400 m)
–4 –3 –2 –1 0 1 2 3 –4 –3 –2 –1 0 1 2 3 4 5
Hypertensive(using log binomial models) found results
that were mostly positive though somewhat
weaker and often included the null value
(data not shown).
Discussion
In this cross-sectional study, PP and SBP
were positively associated with recent ambient
levels of PM2.5 at the participant’s residence.
Associations between PM2.5 and PP persisted
after adjustment for individual level con-
founders, as well as other environmental vari-
ables. PP was 1.12 mmHg higher (95% CI,
0.28–1.97) for each 10-μg/m3 increase in
prior 30-day mean PM2.5 adjusted for person-
level confounders, atmospheric pressure, and
temperature. A 10-μg/m3 increase was
approximately equivalent to the difference in
prior 30-day mean PM2.5 between the 90th
and 10th percentile. Associations between
PM2.5 and SBP were generally weaker except
when gaseous co-pollutants were also adjusted
for: SBP was 2.80 mmHg higher (95% CI,
1.38–4.22) per 10-μg/m3 increase in prior
30-day mean PM2.5. In addition, associations
between particles and BP were stronger in the
presence of trafﬁc-related measures. 
Our results (for SBP, model 2a) were
roughly comparable to the only other study
that found a positive association between
PM2.5 and BP: Zanobetti et al.’s (2004)
repeated-measures study among cardiac
patients which derived exposure from prior
5-day mean PM2.5, and controlled for age, sex,
BMI, number of visits, hour of the day, and
weather. An advantage of our study over prior
work is improved generalizability. Our sample
was large and geographically and demographi-
cally diverse, and participants were generally
healthy. All (non-chamber) studies examining
ﬁne particle effects on BP were among persons
with preexisting disease, and nearly all studies
used a single geographic area (Brauer et al.
2001; Ebelt et al. 2005; Jansen et al. 2005;
Linn et al. 1999; Zanobetti et al. 2004) except
Ibald-Mulli et al.’s study of three cities in
northern Europe (Ibald-Mulli et al. 2004).
Most previous work examining the relation-
ship between BP and PM2.5 has investigated
relatively acute exposures. We found stronger
effects from longer (30- and 60-day) averages
of ambient PM2.5 exposure compared with
shorter (1-, 2-, 7-day) averages, as has been
found for other health outcomes (Diez Roux
et al. 2006). Accumulated exposure may have
a greater impact on health, or smoothing
across wide fluctuations in PM levels may
reduce noise and hence yields better estimates
of (even recent) true background exposure. 
The magnitude of the PM2.5–BP associa-
tions we found were roughly equivalent to a
cross-sectional increase in PP and SBP associ-
ated with aging 1.5 to 3.5 years in our sam-
ple. Although associations of this magnitude
are relatively small, they nevertheless provide
some evidence that BP (or pathways control-
ling vascular homeostasis) might play a medi-
ating role in the association already observed
between particles and cardiovascular morbid-
ity and mortality. There has been growing
interest in the role of PP as a risk factor for
cardiovascular disease (especially among older
adults) (Assmann et al. 2005; Benjo et al.
2007), and we found that among BP-related
outcomes, associations between PM2.5 and PP
tended to be strongest and/or statistically sig-
niﬁcant. This may suggest that, in our sample
of older adults, PM2.5 relates more to pulsatile
stress of large-artery stiffness and impairment
of vascular tone than to other mechanisms in
BP disorders (O’Rourke and Mancia 1999).
Although still positive, in some models there
were weaker results for SBP which may sug-
gest that cardiac ejection is a less important
mechanism than vascular distensibility and
tone. Particles’ potential impairment of vascu-
lar tone is supported by prior work suggesting
that particle inhalation may trigger endothe-
lial dysfunction (Brook et al. 2002; O’Neill
et al. 2005; Tornqvist et al. 2007).
A key mechanism by which particles could
trigger vascular dysfunction is by down-
regulating NO synthase. For example, inhala-
tion of particles via cigarette smoking inhibits
endogenous NO production (Bhatnagar 2006;
Malinovschi et al. 2006). Although reduced
bioavailability of NO contributes to alterations
in BP-related functions (e.g., endothelial func-
tion, activation of the sympathetic system,
platelet functioning) (Bhatnagar 2006; Haak
et al. 1994; Rajagopalan et al. 2005), reduc-
tions in NO also increase the instability of BP
which is itself a risk factor for cardiovascular
disease (Mancia et al. 2001; Stewart et al.
1994). Thus, measures of short-term intraindi-
vidual BP variability could reveal effects that
our measures at a single point in time do not.
Future work could extend this study to a
repeated-measures design permitting improved
control for person-level factors and examina-
tion of within-person variability of BP.
Like previous population-based studies
that examined associations between BP and air
pollution (Harrabi et al. 2006; Ibald-Mulli
et al. 2001), our study included persons taking
BP medications. Medication use is presumably
both a predictor of lower BP and predicted by
BP (medication is prescribed when pressure is
elevated), and thus potentially participates in a
recursive feedback mechanism that is impossi-
ble to model accurately using traditional statis-
tical methods (Wang 2006). Our results were
robust to adjustment for medication use and
other related variables (age, race/ethnicity,
income, and education) and when hyperten-
sion was used as an outcome variable. The
stronger association between particle exposure
and BP among hypertensives and medication
users may suggest that these persons are more
vulnerable to air pollution effects, as found in
previous studies (Frank and Tankersley 2002;
O’Neill et al. 2005).
We found no evidence of a main local
traffic association with BP, although local
traffic exposures modified the association
between background PM2.5 and BP. The lack
of an association with BP may have been
attributable to traffic exposure measurement
error. We were not able to assess closer road-
way exposure [few participants resided within
50 or 100 m of highways, and there were
potential spatial inaccuracies in the relative
positioning of our roadway data and partici-
pant addresses (Wu et al. 2005)], nor differ-
entiate traffic sources most toxic [e.g., diesel
(Brunekreef et al. 1997)]. The stronger associ-
ation between background PM2.5 and BP in
the presence of greater exposure to trafﬁc may
have been attributable to compositional dif-
ferences in PM2.5 near roadways—including a
more toxic mixture of pollutants. A greater
proportion of particles near roadways are
ultraﬁne (< 0.1 μm) (Sanderson et al. 2005),
which are most detrimental to health
(Nemmar et al. 2002; U.S. EPA 2004). In
addition, non-PM2.5 pollutants from road-
ways may potentiate the PM2.5–BP effect: We
found stronger associations in the presence of
high NO2. Differences in particle composi-
tion may have also contributed to stronger
(positive) associations between PM2.5 and BP
during moderate/warm weather, as was seen
in a previous study of PM10 (PM with aero-
dynamic diameter ≤ 10 μm) and BP (Choi
et al. 2007). Photochemical conditions can
increase certain copollutants (e.g., ozone is
highest during warm weather) and pollution
sources may seasonally vary (e.g., vehicular
traffic or types of fuel being burned) (U.S.
EPA 2004). In addition, in moderate/warm
weather, participants may increase their expo-
sure to ambient PM through time spent out-
doors and indoor ventilation from open
windows (Zeka et al. 2006). 
Associations between PM2.5 and BP were
positive and then became much stronger after
adjustment for SO2, NO2, and CO. Although
studies have generally found an unchanged or
weakened effect of PM2.5 on health after adjust-
ment for copollutants (e.g., Zanobetti et al.
2004), a slightly strengthened effect has been
found in some studies (e.g., Miller et al. 2007).
Our results were likely strengthened because of
strong negative confounding by NO2 and (to
some extent) by SO2. An alternate explanation
is that the PM2.5 effect after co-pollutant
adjustment was upwardly biased because of
strong negative correlations among co-pollutant
measurement errors (Zeger et al. 2000). 
We identified PM2.5 exposure using the
monitor nearest each participant’s residence.
Our method is likely an improvement over
Auchincloss et al.
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using a central-city or health clinic monitor-
ing site, which are often used in air pollution
studies (Ibald-Mulli et al. 2004; Zanobetti
et al. 2004). Results were generally insensitive
to participant distance to monitors, likely
because there was high within-site correlation
of background PM2.5 and because most par-
ticipants spent much of their time near their
home. Nevertheless, we acknowledge that our
exposures did not account for within-day expo-
sure variability (e.g., while commuting, at the
workplace) nor indoor particulate levels in gen-
eral. In defense of the measures we used, in the
United States ambient PM2.5 originating from
outside sources appears to be more toxic to
health than PM2.5 originating from indoor
sources (Ebelt et al. 2005). Moreover, our
results were adjusted for smoking and ETS,
which are likely major contributors to indoor
exposures in the population we studied.
In summary, recent exposure to PM2.5 was
positively associated with PP, and the associa-
tion was stronger for residents with higher
exposure to traffic-related measures. Our
results suggest that BP—particularly arterial
stiffness and reductions in vascular tone—may
play a mediating role in associations already
observed between particles and cardiovascular
morbidity and mortality. Given the distal
pathway between environmental exposures
and their potential pathologic effects, it is
noteworthy that we found even a modest asso-
ciation. Because ambient air pollution is ubiq-
uitous, small effects have the potential to
substantially affect public health. This study
provides supportive evidence that reducing
population-level exposures to ambient pollu-
tion can potentially improve population
health. 
REFERENCES
Assmann G, Cullen P, Evers T, Petzinna D, Schulte H. 2005.
Importance of arterial pulse pressure as a predictor of
coronary heart disease risk in PROCAM. Eur Heart J
26(20):2120–2126.
Belsley DA, Kuh E, Welsch RE, eds. 1980. Regression
Diagnostics: Identifying Influential Data and Sources of
Collinearity. New York:John Wiley.
Benjo A, Thompson RE, Fine D, Hogue CW, Alejo D, Kaw A, et al.
2007. Pulse pressure is an age-independent predictor of
stroke development after cardiac surgery. Hypertension
50(4):630–635.
Bhatnagar A. 2006. Environmental cardiology: studying mecha-
nistic links between pollution and heart disease. Circ Res
99(7):692–705.
Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom
AR, et al. 2002. Multi-Ethnic Study of Atherosclerosis: objec-
tives and design. Am J Epidemiol 156(9):871–881.
Brauer M, Ebelt ST, Fisher TV, Brumm J, Petkau AJ, Vedal S.
2001. Exposure of chronic obstructive pulmonary disease
patients to particles: respiratory and cardiovascular health
effects. J Expo Anal Environ Epidemiol 11(6):490–500.
Brauer M, Hoek G, Van Vliet P, Meliefste K, Fischer PH, Wijga A,
et al. 2002. Air pollution from trafﬁc and the development of
respiratory infections and asthmatic and allergic symptoms
in children. Am J Respir Crit Care Med 166(8):1092–1098.
Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S,
Silverman F. 2002. Inhalation of ﬁne particulate air pollution
and ozone causes acute arterial vasoconstriction in
healthy adults. Circulation 105(13):1534–1536.
Brunekreef B, Janssen NA, de Hartog J, Harssema H, Knape M,
van Vliet P. 1997. Air pollution from truck traffic and lung
function in children living near motorways. Epidemiology
8(3):298–303.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA,
Izzo JL Jr, et al. 2003. Seventh report of the Joint National
Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure. Hypertension
42(6):1206–1252.
Choi JH, Xu QS, Park SY, Kim JH, Hwang SS, Lee KH, et al.
2007. Seasonal variation of effect of air pollution on blood
pressure. J Epidemiol Community Health 61(4):314–318.
Diez Roux AV, Auchincloss AH, Astor B, Barr RG, Cushman M,
Dvonch T, et al. 2006. Recent exposure to particulate mat-
ter and C-reactive protein concentration in the Multi-Ethnic
Study of Atherosclerosis. Am J Epidemiol 164(5):437–448.
Diez Roux AV, Chambless L, Merkin SS, Arnett D, Eigenbrodt
M, Nieto FJ, et al. 2002. Socioeconomic disadvantage and
change in blood pressure associated with aging.
Circulation 106(6):703–710.
Dockery DW. 2001. Epidemiologic evidence of cardiovascular
effects of particulate air pollution. Environ Health Perspect
109(suppl 4):483–486.
Durbin J, Watson G. 1951. Testing for serial correlation in least
squares regression. Biometrika 37:409–428.
Ebelt ST, Wilson WE, Brauer M. 2005. Exposure to ambient and
nonambient components of particulate matter: a compari-
son of health effects. Epidemiology 16(3):396–405.
Frank R, Tankersley C. 2002. Air pollution and daily mortality: a
hypothesis concerning the role of impaired homeostasis.
Environ Health Perspect 110:61–65.
GDT and ESRI. 2002. Major Roadways: 1990 Census TIGER/
Line™ File Enhanced Using Dynamap/2000 v9.0. Redlands,
CA:Geographic Data Technology Inc. & Environmental
Systems Research Institute, Inc. 
Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R,
et al. 2003. Follow-up report on the diagnosis of diabetes
mellitus. Diabetes Care 26(11):3160–3167.
Gold DR, Litonjua A, Schwartz J, Lovett E, Larson A, Nearing B,
et al. 2000. Ambient pollution and heart rate variability.
Circulation 101(11):1267–1273.
Haak T, Jungmann E, Raab C, Usadel K. 1994. Elevated
endothelin-1 levels after cigarette smoking. Metabolism
43(3):267–269.
Harrabi I, Rondeau V, Dartigues JF, Tessier JF, Filleul L. 2006.
Effects of particulate air pollution on systolic blood pressure:
a population-based approach. Environ Res 101(1):89–93.
Hastie TJ. 1992. Generalized additive models. In: Statistical
Models in S (Chambers J, Hastie T, eds). Pacific Grove,
CA:Wadsworth & Brooks/Cole, 249–308.
Ibald-Mulli A, Stieber J, Wichmann HE, Koenig W, Peters A.
2001. Effects of air pollution on blood pressure: a popula-
tion-based approach. Am J Public Health 91(4):571–577.
Ibald-Mulli A, Timonen KL, Peters A, Heinrich J, Wolke G, Lanki
T, et al. 2004. Effects of particulate air pollution on blood
pressure and heart rate in subjects with cardiovascular
disease: a multicenter approach. Environ Health Perspect
112:369–377.
Jansen KL, Larson TV, Koenig JQ, Mar TF, Fields C, Stewart J,
et al. 2005. Associations between health effects and par-
ticulate matter and black carbon in subjects with respira-
tory disease. Environ Health Perspect 113:1741–1746.
Kleinbaum D, Kupper L, Muller K, Nizam A. 1998. Applied
Regression Analysis and Other Multivariable Methods. 3rd
ed. Paciﬁc Grove, CA:Duxbury Press.
Künzli N, Jerrett M, Mack WJ, Beckerman B, LaBree L, Gilliland F,
et al. 2005. Ambient air pollution and atherosclerosis in Los
Angeles. Environ Health Perspect 113:201–206.
Lakoski SG, Cushman M, Palmas W, Blumenthal R, D’Agostino
RB Jr, Herrington DM. 2005. The relationship between
blood pressure and C-reactive protein in the Multi-Ethnic
Study of Atherosclerosis (MESA). J Am Coll Cardiol
46(10):1869–1874.
Linn WS, Gong H Jr, Clark KW, Anderson KR. 1999. Day-to-day
particulate exposures and health changes in Los Angeles
area residents with severe lung disease. J Air Waste
Manag Assoc 49(9 spec no):108–115.
Littell R, Milliken G, Stroup W, Wolﬁnger R. 1996. SAS System
for Mixed Models. Cary, NC:SAS Institute Inc.
Malinovschi A, Janson C, Holmkvist T, Norback D, Merilainen P,
Hogman M. 2006. Effect of smoking on exhaled nitric oxide
and flow-independent nitric oxide exchange parameters.
Eur Respir J 28(2):339–345.
Mancia G, Parati G, Hennig M, Flatau B, Omboni S, Glavina F,
et al. 2001. Relation between blood pressure variability
and carotid artery damage in hypertension: baseline data
from the European Lacidipine Study on Atherosclerosis
(ELSA). J Hypertens 19(11):1981–1989.
Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH,
Anderson GL, et al. 2007. Long-term exposure to air pollu-
tion and incidence of cardiovascular events in women.
N Engl J Med 356(5):447–458.
National Climatic Data Center. 2004. NOAA Satellite and
Information Service. Available: http://www.ncdc.noaa.gov/
oa/ncdc.html [accessed 1 December 2004]. 
Nemmar A, Hoet PH, Vanquickenborne B, Dinsdale D, Thomeer
M, Hoylaerts MF, et al. 2002. Passage of inhaled particles
into the blood circulation in humans. Circulation
105(4):411–414.
O’Neill MS, Veves A, Zanobetti A, Sarnat JA, Gold DR,
Economides PA, et al. 2005. Diabetes enhances vulnerabil-
ity to particulate air pollution-associated impairment in
vascular reactivity and endothelial function. Circulation
111(22):2913–2920.
O’Rourke MF, Mancia G. 1999. Arterial stiffness. J Hypertens
17(1):1–4.
Rajagopalan S, Sun Q, Chen LC. 2005. Particulate pollution
and endothelial function: deja vu all over again in the air
[Editorial]. Circulation 111(22):2869–2871.
Sanderson E, Briggs D, Jantunen M, Forsberg B, Svartengren
M, S ˇrám R, et al. 2005. Human exposure to transport-
related air pollution. In: Health Effects of Transport-
Related Air Pollution (Krzyzanowski M, Kuna-Dibbert B,
Schneider J, eds). Copenhagen:World Health Organization
Regional Ofﬁce for Europe.
Stewart MJ, Jyothinagaram S, McGinley IM, Padﬁeld PL. 1994.
Cardiovascular effects of cigarette smoking: ambulatory
blood pressure and BP variability. J Hum Hypertens
8(1):19–22.
Tornqvist H, Mills NL, Gonzalez M, Miller MR, Robinson SD,
Megson IL, et al. 2007. Persistent endothelial dysfunction
following diesel exhaust inhalation in man. Am J Respir
Crit Care Med 176(4):395–400.
Urch B, Silverman F, Corey P, Brook JR, Lukic KZ, Rajagopalan
S, et al. 2005. Acute blood pressure responses in healthy
adults during controlled air pollution exposures. Environ
Health Perspect 113:1052–1055.
U.S. EPA. 2003. Air Quality System (AQS, A Repository of
Ambient Air Quality Data). Research Triangle Park,
NC:U.S. Environmental Protection Agency, Office of Air
Quality Planning and Standards. Available: http://www.
epa.gov/ttn/airs/airsaqs/ [accessed 1 November 2003]. 
U.S. EPA. 2004. The Particle Pollution Report: Current
Understanding of Air Quality and Emissions through 2003.
Research Triangle Park, NC:U.S. Environmental Protection
Agency, Office of Air Quality Planning and Standards;
Emissions, Monitoring, and Analysis Division.
U.S. EPA (U.S. Environmental Protection Agency). 2006.
National Ambient Air Quality Standards. Available: http://
www.epa.gov/air/criteria.html [accessed 1 August 2007]. 
Wang C. 2006. Invited commentary: beyond frequencies and
coefficients—toward meaningful descriptions for life
course epidemiology. Am J Epidemiol 164(2):122–125. 
Woodhouse PR, Khaw KT, Plummer M. 1993. Seasonal variation
of blood pressure and its relationship to ambient tempera-
ture in an elderly population. J Hypertens 11(11):1267–1274.
Wu J, Funk TH, Lurmann FW, Winer AM. 2005. Improving spatial
accuracy of roadway networks and geocoded addresses.
Transactions in GIS 9(4):585–601.
Zanobetti A, Canner MJ, Stone PH, Schwartz J, Sher D, Eagan-
Bengston E, et al. 2004. Ambient pollution and blood pres-
sure in cardiac rehabilitation patients. Circulation
110(15):2184–2189.
Zeger SL, Thomas D, Dominici F, Samet JM, Schwartz J,
Dockery D, et al. 2000. Exposure measurement error in
time-series studies of air pollution: concepts and conse-
quences. Environ Health Perspect 108:419–426.
Zeka A, Zanobetti A, Schwartz J. 2006. Individual-level modi-
ﬁers of the effects of particulate matter on daily mortality.
Am J Epidemiol 163(9):849–859. 